Showing session: reset
Predictive Biomarkers for Immunotherapy
- Sort by:
- Browse by:
- Permission not
granted for presentation
Biomarkers of systemic inflammation associated to reduced clinical activity of atezolizumab monotherapy in patients with metastatic triple negative breast cancer
Luciana Molinero
Genentech, South San Francisco, CA, United States
- Permission not
granted for presentation
A strong HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer is associated with prolonged survival
Cornelis J M Melief
Leiden Univ. Medical Ctr. & ISA Pharmaceuticals BV, Leiden, Netherlands
- Permission not
granted for presentation
Analysis of immune cell infiltrates as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 TRIAL
Michael J Campbell
UCSF, San Francisco, CA, United States
- Free
- slides video
- audio + slides
- All slides included
A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients
Mark H O'Hara
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
Aung Naing
UT MD Anderson Cancer Ctr., Houston, TX, United States